作者
Hetty C de Boer, Coen van Solingen, Jurrien Prins, Jacques MGJ Duijs, Menno V Huisman, Ton J Rabelink, Anton Jan van Zonneveld
发表日期
2013/11/21
期刊
European heart journal
卷号
34
期号
44
页码范围
3451-3457
出版商
Oxford University Press
简介
Aims
MicroRNA-126 (miR-126) facilitates angiogenesis and regulates endothelial cell function. Recent data suggest that miR-126 can serve as a biomarker for vascular disease. Although endothelial cells are enriched for miR-126, platelets also contain miR-126. In this paper, we investigated the contribution of platelets to the pool of miR-126 in plasma of patients with type 2 diabetes (DM2) and how this is affected by aspirin.
Methods and results
In vitro platelet activation resulted in the transfer of miR-126 from the platelet to the plasma compartment, which was prevented by aspirin. In vivo platelet activation, monitored in patients with DM2 by measuring soluble P-selectin, correlated directly with circulating levels of miR-126. The administration of aspirin resulted both in platelet inhibition and concomitantly reduced circulating levels of platelet-derived microRNAs including …
引用总数
2013201420152016201720182019202020212022202320241111201429142213222395
学术搜索中的文章